Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus
Boost your energy, enhance your mood, and support your wellness with our expertly administered treatments
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Lindsay evaluates metabolic health, medical history, and lifestyle factors before prescribing Semaglutide, with careful dosing and ongoing monitoring
Supplement Strategically Clinical studies support the importance of specialized supplementation for GLP-1 medication users [2]
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Duniewska J., Sarnowska A., Bersewicz M., Johnson I., Srai S.K.S., Ramesh B., Goldspink G., Grecki D.C., Zabocka B